|
|||||
|
|
Correction to: Analysis of autonomic outcomes in APOLLO,a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis |
|
| Authors: | González-Duarte Alejandra Berk John L Quan Dianna Mauermann Michelle L Schmidt Hartmut H Polydefkis Michael Waddington-Cruz Márcia Ueda Mitsuharu Conceição Isabel M Kristen Arnt V Coelho Teresa Cauquil Cécile A Tard Céline Merkel Madeline Aldinc Emre Chen Jihong Sweetser Marianne T Wang Jing Jing Adams David |
| Institution: | 1.Instituto Nacional de Ciencias Médicas Y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Tlalpan, CdMx, CP 01400, México City, Mexico ;2.Boston Medical Center, Boston, MA, USA ;3.University of Colorado, Denver, CO, USA ;4.Mayo Clinic, Rochester, MN, USA ;5.University of Münster, Münster, Germany ;6.Johns Hopkins University School of Medicine, Baltimore, MD, USA ;7.Hospital Universitário Clementino Fraga Filho-UFRJ, Rio de Janeiro, Brazil ;8.Kumamoto University Hospital, Kumamoto, Japan ;9.CHULN, Hospital de Santa Maria and Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal ;10.University of Heidelberg, Heidelberg, Germany ;11.Hospital de Santo António, Centro Hospitalar Universitário Do Porto, Porto, Portugal ;12.AP-HP Université Paris Saclay, CHU Bicêtre, Le Kremlin Bicêtre, France ;13.Université de Lille, Lille, France ;14.Alnylam Pharmaceuticals, Cambridge, MA, USA ;15.AP-HP, Université Paris Saclay, CHU Bicêtre, Université Paris-Sud, INSERM 1195, Paris, France ; |
| Abstract: | Journal of Neurology - The original version of this article unfortunately contained a mistake. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |